Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Akebia Therapeutics (AKBA) Tax Provisions: 2018-2019

Historic Tax Provisions for Akebia Therapeutics (AKBA) over the last 2 years, with Dec 2019 value amounting to -$6.6 million.

  • Akebia Therapeutics' Tax Provisions was N/A to $615,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.1 million, marking a year-over-year change of. This contributed to the annual value of -$6.6 million for FY2019, which is 76.60% up from last year.
  • As of FY2019, Akebia Therapeutics' Tax Provisions stood at -$6.6 million, which was up 76.60% from -$28.3 million recorded in FY2018.
  • Over the past 5 years, Akebia Therapeutics' Tax Provisions peaked at -$6.6 million during FY2019, and registered a low of -$28.3 million during FY2018.
  • Over the past 2 years, Akebia Therapeutics' median Tax Provisions value was -$17.5 million (recorded in 2018), while the average stood at -$17.5 million.
  • Data for Akebia Therapeutics' Tax Provisions shows a peak YoY spiked of 76.60% (in 2019) over the last 5 years.
  • Yearly analysis of 2 years shows Akebia Therapeutics' Tax Provisions stood at -$28.3 million in 2018, then surged by 76.60% to -$6.6 million in 2019.